FGP
CAH icon

Freestone Grove Partners’s Cardinal Health CAH Stock Holding History

Freestone Grove Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.6M Buy
329,210
+77,019
+31% +$16.6M 0.49% 47
2025
Q4 		$51.8M Sell
252,191
-212,379
-46% -$40M 0.37% 78
2025
Q3 		$72.9M Buy
464,570
+153,690
+49% +$23.7M 0.54% 39
2025
Q2 		$52.2M Sell
310,880
-188,090
-38% -$27.9M 0.39% 87
2025
Q1 		$68.7M Buy
498,970
+188,589
+61% +$24M 0.71% 30
2024
Q4 		$36.7M Buy
+310,381
New +$36.2M 0.45% 73

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Freestone Grove Partners's CAH Position: Q1 2026 in Review

Freestone Grove Partners increased its Cardinal Health (CAH) stake by 31% in Q1 2026, buying an estimated $16.6M and bringing the position to 329,210 shares worth $69.6M. The position accounts for 0.49% of the portfolio, ranked #47.

Freestone Grove Partners first reported a position in CAH in Q4 2024 and has held it in 6 quarters since. The position peaked at $72.9M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Freestone Grove Partners held 329,210 shares of Cardinal Health worth $69.6M as of Q1 2026.
  • Freestone Grove Partners bought 77,019 Cardinal Health shares in Q1 2026, an estimated $16.6M.
  • Cardinal Health made up 0.49% of Freestone Grove Partners's portfolio in Q1 2026, its #47 holding.
  • Freestone Grove Partners first reported a position in Cardinal Health in Q4 2024 and has held it in 6 quarters since.
  • Freestone Grove Partners's Cardinal Health position peaked at $72.9M in Q3 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.